Publications by authors named "Sanne van der Wiel"
Article Synopsis
- A study examined variations in treatment outcomes and costs of inflammatory bowel disease (IBD) across 8 hospitals in the Netherlands, focusing on how these differences can inform quality and cost improvements in care.
- The study included 1010 patients and found that while clinicians reported high remission rates (83%), patient-reported rates were significantly lower (40%), indicating discrepancies in perceived outcomes.
- Most variations in treatment outcomes and costs were linked to individual patient factors rather than the hospitals themselves, suggesting that future efforts should concentrate on enhancing patient-level care rather than evaluating hospitals based on these variations.
[Treatment of inflammatory bowel disease: what if drug therapy fails?].
Ned Tijdschr Geneeskd
December 2014
The treatment of patients with chronic inflammatory bowel disease (IBD) in accordance with the current guideline is generally successful but there is still a group of patients for whom the medication does not work. If the initially prescribed medication is not sufficiently effective, the tendency is to move on to a 'higher' class of drugs relatively quickly. This is not always necessary.
View Article and Find Full Text PDF